NO883594L - Fremgangsmaate for fremstilling av preparater av dobbeltraadet rna. - Google Patents

Fremgangsmaate for fremstilling av preparater av dobbeltraadet rna.

Info

Publication number
NO883594L
NO883594L NO88883594A NO883594A NO883594L NO 883594 L NO883594 L NO 883594L NO 88883594 A NO88883594 A NO 88883594A NO 883594 A NO883594 A NO 883594A NO 883594 L NO883594 L NO 883594L
Authority
NO
Norway
Prior art keywords
various
procedure
preparation
rna preparations
double wired
Prior art date
Application number
NO88883594A
Other languages
English (en)
Norwegian (no)
Other versions
NO883594D0 (no
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of NO883594D0 publication Critical patent/NO883594D0/no
Publication of NO883594L publication Critical patent/NO883594L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO88883594A 1987-08-12 1988-08-12 Fremgangsmaate for fremstilling av preparater av dobbeltraadet rna. NO883594L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8422787A 1987-08-12 1987-08-12

Publications (2)

Publication Number Publication Date
NO883594D0 NO883594D0 (no) 1988-08-12
NO883594L true NO883594L (no) 1989-02-13

Family

ID=22183617

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88883594A NO883594L (no) 1987-08-12 1988-08-12 Fremgangsmaate for fremstilling av preparater av dobbeltraadet rna.

Country Status (19)

Country Link
EP (1) EP0308066B1 (de)
JP (1) JPH01131119A (de)
KR (1) KR0131879B1 (de)
CN (1) CN1050995C (de)
AT (1) ATE132041T1 (de)
AU (3) AU2053588A (de)
CA (1) CA1327002C (de)
DE (1) DE3854829T2 (de)
DK (1) DK449888A (de)
FI (1) FI883763A7 (de)
HU (1) HUT47854A (de)
IE (1) IE72103B1 (de)
IL (1) IL87413A0 (de)
NO (1) NO883594L (de)
NZ (1) NZ225799A (de)
OA (1) OA08901A (de)
PT (1) PT88266B (de)
RU (1) RU1834663C (de)
ZA (1) ZA885967B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593973A (en) * 1987-09-04 1997-01-14 Hemispherx Biopharma Inc. Treatment of viral hepatitis with mismatched dsRNA
EP0306347B1 (de) * 1987-09-04 1995-05-10 Hem Pharmaceuticals Corp. Diagnose von Mangelzuständen doppelsträngiger RNS
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape
EP0378621A4 (en) * 1988-05-23 1991-08-28 Steffen Gay Diagnostics and therapy for rheumatoid arthritis
EP0473576A4 (en) * 1989-05-19 1993-03-10 Hem Research, Inc. Short therapeutic dsrna of defined structure
ZA908037B (en) * 1989-10-11 1991-09-25 Hem Res Inc Protection from shock subsequent to injury by double-standed rnas
WO1991005560A1 (en) * 1989-10-11 1991-05-02 Hem Research, Inc. PROTECTION FROM SHOCK SUBSEQUENT TO INJURY BY DOUBLE-STRANDED RNAs
HUT65370A (en) * 1989-10-16 1994-05-02 Hem Res Inc Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction
CA2120027A1 (en) * 1991-09-26 1993-04-01 William A. Carter Method of neutralizing il-1 using dsrnas
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
WO1999049029A1 (en) 1998-03-20 1999-09-30 Benitec Australia Ltd Control of gene expression
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
EP1147204A1 (de) 1999-01-28 2001-10-24 Medical College Of Georgia Research Institute, Inc. Zusammensetzung und verfahren zur in vivo und in vitro abschwächung der genexpression mittels dobbelsträngigem rna
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
CA2369944A1 (en) 2001-01-31 2002-07-31 Nucleonics Inc. Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
CA2482903A1 (en) * 2002-04-18 2003-10-23 Lynkeus Biotech Gmbh Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
US7148342B2 (en) 2002-07-24 2006-12-12 The Trustees Of The University Of Pennyslvania Compositions and methods for sirna inhibition of angiogenesis
WO2004022075A1 (en) * 2002-09-04 2004-03-18 Novartis Ag Treatment of neurological disorders by dsrna adminitration
EP2134172A4 (de) * 2007-03-05 2011-06-01 Univ Utah State Restriktiver agonist des toll-like-rezeptors 3
CA2745832A1 (en) 2008-12-04 2010-06-10 Opko Ophthalmics, Llc Compositions and methods for selective inhibition of pro-angiogenic vegf isoforms
CN109355334A (zh) * 2018-12-06 2019-02-19 江苏省农业科学院 一种制备聚肌胞的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)
AU1820388A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles

Also Published As

Publication number Publication date
ATE132041T1 (de) 1996-01-15
CA1327002C (en) 1994-02-15
FI883763L (fi) 1989-02-13
PT88266A (pt) 1989-06-30
EP0308066A2 (de) 1989-03-22
EP0308066B1 (de) 1995-12-27
DE3854829T2 (de) 1996-08-14
KR890003402A (ko) 1989-04-14
DK449888A (da) 1989-02-13
IL87413A0 (en) 1989-01-31
DE3854829D1 (de) 1996-02-08
DK449888D0 (da) 1988-08-11
EP0308066A3 (de) 1991-01-16
FI883763A0 (fi) 1988-08-12
RU1834663C (ru) 1993-08-15
NO883594D0 (no) 1988-08-12
AU2053588A (en) 1989-04-20
PT88266B (pt) 1995-05-04
CN1032740A (zh) 1989-05-10
FI883763A7 (fi) 1989-02-13
JPH01131119A (ja) 1989-05-24
AU1001595A (en) 1995-02-23
ZA885967B (en) 1989-07-26
IE72103B1 (en) 1997-03-12
AU1736792A (en) 1992-07-30
CN1050995C (zh) 2000-04-05
HUT47854A (en) 1989-04-28
IE882399L (en) 1989-02-12
NZ225799A (en) 1991-04-26
KR0131879B1 (ko) 1998-04-17
OA08901A (en) 1989-10-31

Similar Documents

Publication Publication Date Title
NO883594D0 (no) Fremgangsmaate for fremstilling av preparater av dobbeltraadet rna.
EP0400958A3 (de) Lebende Impfstoffe
ATE116637T1 (de) Sulfonische stilbenderivate zur behandlung von viruserkrankungen.
CA2314170A1 (en) Method of the prophylactic treatment of mastitis
GR3022801T3 (en) Phenylalkan(en)oic acids with leukotriene B4 antagonistic activity.
JPS5519239A (en) Interferon-producing attractant
AU5684286A (en) Use of an aqueous, stabilised chlorite matrix solution for infectious conditions
WHEELER et al. Influence of specific antibody on herpes simplex infections in tissue culture
ES8704962A1 (es) Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida.
DE3767308D1 (de) Verwendung von sulfonamidderivaten zur herstellung eines antivirusmittels.
Vignaux et al. Enhanced expression of histocompatibility antigens on interferon-treated mouse embryonic fibroblasts
NO920255D0 (no) Podofyllotoksinpreparat som inneholder triglyserider
PT87940A (pt) Processo para a preparacao de dna do virus papillom humano tipo 41 e de proteinas por ele codificadas
Wargo Interaction of stress and secondary organisms in decline of forest trees.
DE69110470D1 (de) Herstellung von erhöhten Biokontrollwirkstoffen.
JPS5636483A (en) 66imidazolyll33hydrazinoopyridazine* its manufacture and medicine containing it
ES8104402A1 (es) Procedimiento para la preparacion de medicamentos inmunobio-terapicos a partir de cepas microbiologicas.
JPS5639098A (en) Novel oligosaccharide and its preparation
WO1988008707A3 (en) Rubradirin derivatives for treatment of hiv infection
JPS5492680A (en) Novel microorganism
ES2194860T3 (es) Composiciones que contienen timosina alfa 1 destinadas al tratamiento de pacientes que sufren una enfermedad hepatica descompensada.
KR870009018A (ko) 단순 포진에 대한 왁진